PT  - JOURNAL ARTICLE
AU  - Hepbildikler, Stefan
AU  - Nothelfer, Franz
TI  - Proceedings of the 2017 Viral Clearance Symposium - Introduction
AID  - 10.5731/pdajpst.2018.009076
DP  - 2018 Jan 01
TA  - PDA Journal of Pharmaceutical Science and Technology
PG  - pdajpst.2018.009076
4099  - http://journal.pda.org/content/early/2018/07/03/pdajpst.2018.009076.short
4100  - http://journal.pda.org/content/early/2018/07/03/pdajpst.2018.009076.full
AB  - This article introduces the white paper from the 2017 Viral Clearance Symposium. The 5th Viral Clearance Symposium 2017 in Penzberg, Germany, addressed regulatory perspectives presented by officials from Health Canada, FDA and PEI, as well as Upstream and Facility risk mitigation, Downstream unit operations, and viral clearance strategies to support novel molecule formats, accelerated scenarios and continuous processing.